Kintara Therapeutics, Inc.
KTRA
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 219.80% | 22.25% | -90.47% | -96.95% | -86.97% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -37.27% | -74.67% | -71.18% | -47.06% | -55.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -80.93% | -- | -- | -- | -- |
Total Current Assets | 69.05% | 12.28% | -87.08% | -90.40% | -75.34% |
|
|||||
Total Current Assets | 69.05% | 12.28% | -87.08% | -90.40% | -75.34% |
Net Property, Plant & Equipment | -4.94% | -4.56% | -5.41% | -7.96% | 687.78% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 55.87% | 10.47% | -80.99% | -88.82% | -75.05% |
|
|||||
Total Accounts Payable | -20.73% | -52.38% | -36.01% | 1.87% | -14.84% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -82.55% | -45.56% | -72.99% | -41.01% | -58.67% |
Total Other Current Liabilities | -82.55% | -45.56% | -72.99% | -41.01% | -58.67% |
Total Current Liabilities | -26.70% | -51.94% | -42.27% | -5.12% | -22.76% |
|
|||||
Total Current Liabilities | -26.70% | -51.94% | -42.27% | -5.12% | -22.76% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 12.05% | 11.59% | 123.75% | 119.74% | 1.84% |
Total Liabilities | -24.72% | -48.41% | -38.26% | -2.48% | -21.79% |
|
|||||
Common Stock & APIC | 8.43% | 8.53% | 3.22% | 2.53% | 4.33% |
Retained Earnings | -5.62% | -6.43% | -7.44% | -9.34% | -11.01% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | 34.49% | 36.87% | -149.31% | -330.31% | -1,206.19% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock Convertible | -3.79% | -3.79% | -4.99% | -15.85% | -15.55% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -3.69% | -3.69% | -4.86% | -15.50% | -15.21% |
|
|||||
Total Common Equity | 34.49% | 36.87% | -149.31% | -330.31% | -1,206.19% |
Total Preferred Equity | -3.69% | -3.69% | -4.86% | -15.50% | -15.21% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 413.95% | 56.42% | -102.49% | -121.06% | -93.80% |
|